Sort
50,496 grants matching “lung cancer”
INVESTIGATING NAPDH OXIDASES AND REDOX SIGNALING IN LUNG CANCER TUMORIGENICITY
$554,382Jason M. Held · Washington University · R01 · FY2020 · CA
Genetic and Pharmacogenetic Modifiers of Cancer Risk and Intervention Outcomes
$554,334Mark H Greene · Division Of Cancer Epidemiology And Genetics · ZIA · FY2012 · CA
Imaging the multifaceted response to a bispecific antibody therapy
$554,306Bernadette Marquez-Nostra · Yale University · R01 · FY2022 · CA
Identifying and Targeting Mechanisms for Membrane Signaling in Human Cancer
$554,274Eric Alejandro Sweet-Cordero · University Of California, San Francisco · R01 · FY2025 · CA
Clinical Protocols in the Cancer Signaling Networks Section
$554,270Udayan Guha · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Data Processing, Analysis and Modeling Unit
$554,259Dana Pe'er · Sloan-Kettering Inst Can Research · U2C · FY2020 · CA
Elucidating pro-metastatic collagen modifying activities of lysyl hydroxylase 2
$554,196Jonathan M Kurie · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · CA
Electronic cigarette derived free radicals, oxidative stress and inflammation in lung cancer development
$554,155Jay Louis Zweier · Ohio State University · R01 · FY2023 · CA
Mechanical Stress and Lung Tumor Progression
$554,133Jeffrey A. Weiss · University Of Utah · R01 · FY2024 · CA
A Novel Anti-HER2/neu IgE for Breast Cancer Therapy
$554,058Manuel L Penichet · University Of California Los Angeles · R01 · FY2017 · CA
INFRASRUCTURE SUPPORT AND DATA ENHANCEMENTS FOR THE CARET BIOREPOSITORY
$554,050Gary E Goodman · Fred Hutchinson Cancer Research Center · UM1 · FY2015 · CA
Research Project
$553,953Christi A Patten · Mayo Clinic Rochester · U54 · FY2010 · CA
A Metabolic Target for Lung Cancer Prevention
$553,797Johns Hopkins University · R01 · FY2005 · CA
Project 4: Quantification and Biomarkers of Short-Term Pulmonary Effect p302-340
$553,795Carolyn Calfee · University Of California, San Francisco · P50 · FY2014 · CA
Role of IRF2 in cancer immune evasion and immunotherapy
$553,729Kenneth L Rock · Univ Of Massachusetts Med Sch Worcester · R01 · FY2024 · CA
(PQD1) lmpact of cytotoxic and targeted therapy on clonal evolution of CLL
$553,684Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · R01 · FY2017 · CA
(PQD1) lmpact of cytotoxic and targeted therapy on clonal evolution of CLL
$553,684Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · R01 · FY2016 · CA
(PQD1) lmpact of cytotoxic and targeted therapy on clonal evolution of CLL
$553,684Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · R01 · FY2014 · CA
(PQD1) lmpact of cytotoxic and targeted therapy on clonal evolution of CLL
$553,684Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · R01 · FY2015 · CA
Data Processing, Analysis and Modeling Unit
$553,655Dana Pe'er · Sloan-Kettering Inst Can Research · U2C · FY2019 · CA
Minority-Based CCOP at UMDNJ-NJ Medical School/University Hospital Cancer Center
$553,640Robert Wieder · Rbhs-New Jersey Medical School · U10 · FY2013 · CA
Helicobacter pylori protein-specific antibodies and colorectal cancer risk
$553,627Meira Epplein · Duke University · R01 · FY2017 · CA
TCR signaling and cell cycle regulation in tumor-specific CD8 T cell dysfunction
$553,614Mary Philip · Vanderbilt University Medical Center · R37 · FY2025 · CA
An AI-enabled Digital Pathology Platform for Multi-Cancer Diagnosis, Prognosis and Prediction of Therapeutic Benefit
$553,532Anant Madabhushi · Emory University · U01 · FY2023 · CA
A deubiquitination module controls Treg adaptation to tumor microenvironment
$553,526Deyu Fang · Northwestern University At Chicago · R01 · FY2022 · CA